Cargando…

Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma

OBJECTIVE: Annexin A1 (ANXA1) is a calcium-dependent phospholipid-binding protein which contributes to proliferation, cancer progression and metastasis. Overexpression of ANXA1 is closely associated with metastasis in numerous types of cancer. Cholangiocarcinoma (CCA) is a bile-duct cancer which has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotepui, Kwuntida U, Obchoei, Sumalee, Vaeteewoottacharn, Kulthida, Okada, Seiji, Wongkham, Sopit, Sawanyawisuth, Kanlayanee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272612/ https://www.ncbi.nlm.nih.gov/pubmed/35225485 http://dx.doi.org/10.31557/APJCP.2022.23.2.715

Ejemplares similares

Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma
por: Sribenja, Sirinapa, et al.
Publicado: (2013)

Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model
por: Saisomboon, Saowaluk, et al.
Publicado: (2019)

Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process
por: Dana, Paweena, et al.
Publicado: (2017)

Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor
por: Obchoei, Sumalee, et al.
Publicado: (2022)

Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma
por: Obchoei, Sumalee, et al.
Publicado: (2011)

Reversine, a selective MPS1 inhibitor, induced autophagic cell death via diminished glucose uptake and ATP production in cholangiocarcinoma cells
por: Prajumwongs, Piya, et al.
Publicado: (2021)

Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB
por: Phoomak, Chatchai, et al.
Publicado: (2016)

Dense GM-CSFRα-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients
por: Saranaruk, Paksiree, et al.
Publicado: (2023)

O‐GlcNAc‐induced nuclear translocation of hnRNP‐K is associated with progression and metastasis of cholangiocarcinoma
por: Phoomak, Chatchai, et al.
Publicado: (2019)

Chromomycin A3 suppresses cholangiocarcinoma growth by induction of S phase cell cycle arrest and suppression of Sp1-related anti-apoptotic proteins
por: Saranaruk, Paksiree, et al.
Publicado: (2020)

High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation
por: Phoomak, Chatchai, et al.
Publicado: (2017)

O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1
por: Phoomak, Chatchai, et al.
Publicado: (2018)

Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells
por: Seubwai, Wunchana, et al.
Publicado: (2016)

High Monopolar Spindle 1 Is Associated with Short Survival of Cholangiocarcinoma Patients and Enhances the Progression Via AKT and STAT3 Signaling Pathways
por: Prajumwongs, Piya, et al.
Publicado: (2021)

Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis()()
por: Vaeteewoottacharn, Kulthida, et al.
Publicado: (2018)

Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway
por: Dana, Paweena, et al.
Publicado: (2021)

Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells
por: Saentaweesuk, Waraporn, et al.
Publicado: (2018)

Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway
por: Indramanee, Somsiri, et al.
Publicado: (2019)

Establishment of an Allo-Transplantable Hamster Cholangiocarcinoma Cell Line and Its Application for In Vivo Screening of Anti-Cancer Drugs
por: Puthdee, Nattapong, et al.
Publicado: (2013)

Establishment and characterization of a novel cancer stem‐like cell of cholangiocarcinoma
por: Panawan, Orasa, et al.
Publicado: (2023)

Inhibitory Effect of Aspirin on Cholangiocarcinoma Cells
por: Boueroy, Parichart, et al.
Publicado: (2017)

Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model
por: Vaeteewoottacharn, Kulthida, et al.
Publicado: (2019)

FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients
por: Klinhom-on, Nathakan, et al.
Publicado: (2021)

Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients
por: Wattanavises, Sasiprapa, et al.
Publicado: (2019)

Comprehensive drug response profiling and pan-omic analysis identified therapeutic candidates and prognostic biomarkers for Asian cholangiocarcinoma
por: Jamnongsong, Supawan, et al.
Publicado: (2022)

The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells
por: Utaijaratrasmi, Penkhae, et al.
Publicado: (2018)

in Vitro and in Vivo Inhibitory Effects of α-Mangostin on Cholangiocarcinoma Cells and Allografts
por: Aukkanimart, Ratchadawan, et al.
Publicado: (2017)

High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation
por: Saengboonmee, Charupong, et al.
Publicado: (2016)

Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma
por: Sungwan, Prin, et al.
Publicado: (2021)

Aberrant Expression of NF-κB in Liver Fluke Associated Cholangiocarcinoma: Implications for Targeted Therapy
por: Seubwai, Wunchana, et al.
Publicado: (2014)

Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models
por: Okada, Seiji, et al.
Publicado: (2019)

Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients
por: Chua-on, Daraporn, et al.
Publicado: (2020)

Epithelial–Mesenchymal Transition in Liver Fluke-Induced Cholangiocarcinoma
por: Sawanyawisuth, Kanlayanee, et al.
Publicado: (2021)

A Novel Predictive Equation for Potential Diagnosis of Cholangiocarcinoma
por: Kraiklang, Ratthaphol, et al.
Publicado: (2014)

High level of interleukin-33 in cancer cells and cancer-associated fibroblasts correlates with good prognosis and suppressed migration in cholangiocarcinoma
por: Yangngam, Supaporn, et al.
Publicado: (2020)

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2018)

High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8
por: Thonsri, Unchalee, et al.
Publicado: (2020)

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2021)

A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Butea monosperma Agglutinin
por: Teeravirote, Karuntarat, et al.
Publicado: (2021)

Aberrant mRNA splicing generates oncogenic RNA isoforms and contributes to the development and progression of cholangiocarcinoma
por: Yosudjai, Juthamas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8r0hb111e8lvch6i4tatbugh6g